Innoverda

What Innoverda does

Innoverda is a French specialty chemistry company that develops electrochemical processes, principally electrosynthesis and electrodialysis, for the pharmaceutical and cosmetic industries. The company's core technology replaces conventional chemical production inputs, including corrosive/toxic reagents, non-renewable raw materials, large volumes of organic solvents, and high temperatures/pressures, with electrically driven reactions that deliver the same molecular outputs with reduced cost and environmental impact. The central technical barrier, and Innoverda's core expertise, is the characterization and optimization of electrochemical parameters to achieve optimal yields; this capability has been developed over several years by founder Irene Erdelmeier (15+ international patents) and a small in-house team of synthetic chemists and R&D specialists.

The business operates a three-phase service model: a 3-7 day feasibility study to estimate the potential improvement from the electrochemical route, a 2-week to 2-month pre-pilot study that determines yield within ±20% accuracy on average, and full-scale production at kilogram scale using owned equipment. Demonstrated outcomes include a 40% production cost reduction for a cosmetic ingredient client (5 kg/month output) and a minimum 30% cost reduction estimated at the pre-pilot stage. Customer acquisition is direct B2B, targeting pharmaceutical and cosmetic ingredient manufacturers; only one named customer case study is publicly disclosed. Pricing is quote-based and not publicly disclosed.

Innoverda was acquired by DIVERCHIM, a major CDMO (Contract Development and Manufacturing Organization) in the drug substance field, in late 2024/early 2025, and the team relocated to Diverchim's Roissy-en-France facility in June 2025. The acquisition provides GMP production capabilities and access to Diverchim's CDMO commercial network, materially expanding Innoverda's scale-up and commercial reach. Prior to acquisition, the company's only disclosed funding was the Innov'up faisabilité grant from Bpifrance (October 2020), and it was recognized in the French environmental startup mapping by France Digital and Bpifrance Le Hub in July 2021.

Name

Innoverda

Legal name

Innoverda

Website

https://innoverda.com

Company type

Private

Operating status

Acquired

Headcount range

1–10 employees

Short description

Innoverda is a French specialty chemistry company that develops electrochemical processes (electrosynthesis and electrodialysis) for pharmaceutical and cosmetic ingredient manufacturers, reducing production costs and environmental impact. Acquired by CDMO DIVERCHIM in 2025.

Ownership category

akta.pro rank

Headquarters

HQ city

Villejuif

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Feasibility Studies: Initial assessment service lasting 3-7 days to estimate potential improvement via electrochemical route. Entry point for customer acquisition and relationship development.
2. Pre-Pilot Studies: In-depth study lasting approximately 2 weeks to 2 months, determining electrochemical yield within +/- 20% accuracy on average. Bridges feasibility to full production.
3. Chemical Production: Full-scale production service using owned equipment to manufacture several kilograms of product per month. Direct manufacturing revenue from pharmaceutical and cosmetic ingredient production.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Innoverda develops electrochemical (electrosynthesis) processes and delivers them as a three-stage service portfolio for pharmaceutical and cosmetic ingredient manufacturers: Feasibility Study (3–7 days), Pre-pilot Study (2 weeks to 2 months), and Production (kilogram-scale manufacturing using its own equipment). The services replace corrosive/toxic reagents with electrical energy to reduce production costs and environmental impact.

Product overview

Innoverda offers a three-stage service portfolio for electrochemical chemical production: Feasibility Study (3-7 days), Pre-pilot Study (2 weeks to 2 months), and Production services capable of manufacturing several kilograms per month. These services target pharmaceutical and cosmetic industries, focusing on reducing production costs and environmental impact through electrosynthesis technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Feasibility Study (Étude de faisabilité) A 3 to 7 day assessment that estimates the potential for improvement via electrochemical route for a customer's chemical production; entry-point service for pharmaceutical and cosmetic manufacturers.
• Pre-pilot Study (Étude pré-pilote) An in-depth study lasting approximately two weeks to two months that determines electrochemical yield within roughly ±20% accuracy on average, bridging feasibility to full production for pharmaceutical and cosmetic manufacturers.
• Production Contract manufacturing service using Innoverda's owned electrochemical equipment to produce several kilograms of chemical product per month for pharmaceutical and cosmetic customers following successful feasibility and pre-pilot studies.

Quantifiable outcome

• 40% reduction in production costs achieved for cosmetic ingredient client
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• DIVERCHIMcoreStrategic or Co-development Partner · 1 January 2025Innoverda was acquired by DIVERCHIM, a major CDMO (Contract Development and Manufacturing Organization) player in drug substance field. This strategic acquisition enhances scale-up possibilities for electrosynthesis and electrodialysis, including GMP production capabilities. Innoverda relocated to DIVERCHIM's facility in Roissy-en-France.
• CNAM (Conservatoire National des Arts et Métiers)minorStrategic or Co-development PartnerAcademic partner for research and development collaboration in chemistry and related fields.
• Climate-KICminorStrategic or Co-development PartnerEuropean Climate Knowledge and Innovation Community partner supporting climate-focused innovation.
• European Commission (Seal of Excellence)minorStrategic or Co-development PartnerRecognized with Seal of Excellence for research and innovation quality.
• University of Paris (U Paris)minorStrategic or Co-development PartnerAcademic research partner.
• Green Chemistry and Commerce Council (GC3)minorStrategic or Co-development PartnerCollaborative network promoting green chemistry commercial applications.
• UN EnvironmentminorStrategic or Co-development PartnerUnited Nations Environment Programme partnership supporting sustainable chemical production.
• UNIDOminorStrategic or Co-development PartnerUnited Nations Industrial Development Organization partnership for sustainable industrial development.
• ISC3 (International Sustainable Chemistry Collaborative Centre)minorStrategic or Co-development PartnerInternational partnership for sustainable chemistry advancement.
• IAR PoleminorStrategic or Co-development PartnerFrench competitiveness cluster for industrial biotechnology and green chemistry.
• MiEl ProjectminorStrategic or Co-development PartnerEuropean research project partnership.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Carbios: Carbios is a French green chemistry company that develops enzymatic recycling and bioprocesses for polymers and specialty chemicals. It is regionally comparable to Innoverda as another French sustainable chemistry innovator applying biological/alternative process technologies to industrial chemical manufacturing.

Emerging players

• Novonix: Novonix develops and manufactures electrochemical materials and processes, primarily for batteries and energy storage. It is comparable to Innoverda as a company building a commercial business around electrochemical process technology, though applied to energy materials rather than pharmaceutical ingredients.
• Solugen: Solugen produces plant-based, sustainable chemicals through bio-derived processes for industrial customers, including personal care and specialty chemicals. It is comparable to Innoverda as a green chemistry innovator serving personal care/cosmetic and industrial chemical markets with sustainable production methods.
• Syzygy Plasmonics: Syzygy Plasmonics uses photocatalysis and electrochemical methods to produce industrial chemicals such as hydrogen and fuels. It is comparable to Innoverda as an emerging company using electrochemistry-driven process technology to produce chemicals with sustainability benefits over conventional routes.

Broad incumbents

• WuXi AppTec: WuXi AppTec is one of the largest global CDMOs, providing drug discovery, development, and manufacturing services across small molecules, biologics, and cell/gene therapies. It is comparable to Innoverda as a broad incumbent offering pharmaceutical contract services including custom synthesis and scale-up.
• Catalent: Catalent is a global CDMO providing drug substance and drug product development and manufacturing services to pharmaceutical customers. It is comparable to Innoverda as a broad incumbent in the same pharmaceutical contract manufacturing space, though operating at much larger scale with a broader service portfolio.
• Lonza: Lonza is a leading global CDMO offering small molecule and biologics manufacturing services to pharma and consumer health companies. It is comparable to Innoverda as a broad incumbent CDMO serving pharmaceutical customers with custom synthesis and process development, albeit at global scale and across multiple modalities.
• AGC Pharma Chemicals: AGC Pharma Chemicals is the CDMO division of AGC offering API manufacturing and custom synthesis services to pharmaceutical customers. It is comparable to Innoverda as a broad incumbent CDMO providing API and intermediate manufacturing for pharma clients.

Direct peers

• DIVERCHIM: DIVERCHIM is the parent company of Innoverda and a major French CDMO operating in the drug substance field. It provides GMP production capabilities and serves pharmaceutical clients with custom synthesis and contract manufacturing, directly comparable to Innoverda's CDMO-style service offering.
• EnginZyme: EnginZyme is a Swedish green chemistry company that uses biocatalysis and process development to enable sustainable chemical manufacturing, with pharmaceutical applications. Like Innoverda, it provides process development services that replace traditional chemistry with greener alternatives, addressing similar customer pain points in pharma and specialty chemicals.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/innoverda
• Facebookfacebook.com/innoverda

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innoverda